BERLIN and BOSTON, April 18, 2023 /PRNewswire/ — Cambrium, a leading German start-up focused on the application of generative AI to protein design and synthesis, and Ginkgo Bioworks (NYSE: DNA, “Ginkgo”), which is building the leading platform for cell programming and biosecurity, today announced the successful completion of their collaboration.…Read More
Cambrium and Ginkgo Bioworks Complete Successful Collaboration on DataDriven Cell Factory Engineering
